Interleukin 18 and periodontal disease

Journal of Dental Research

Volumn 86, Issue 7, 2007, Pages 586-593

  Orozco, A ^a   Gemmell, E ^a   Bickel, M ^a   Seymour, G J ^b  

^a School of Dentistry   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cytokines; Gingivitis; IL 18; Periodontitis

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR;

ANIMAL; GENETICS; GINGIVITIS; HUMAN; IMMUNOLOGY; PERIODONTITIS; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ANIMALS; GINGIVITIS; HUMANS; INTERLEUKIN-12; INTERLEUKIN-18; PERIODONTITIS; RECEPTORS, INTERLEUKIN-18; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS;

EID: 34547190348     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910708600702     Document Type: Article

References (103)

1. Abbas AK, Lichtman AH (2003). Cellular and molecular immunology. 5th ed. Philadelphia: Saunders.
2. Akita K, Ohtsuki T, Nukada Y, Tanimoto T, Namba M, Okura T, et al (1997). Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP. 1 cells. J Biol Chem 272:26595-26603.
3. Balkwill FR, Burke F (1989). The cytokine network. Immunology Today 10:299-304.
4. Beck JD, Offenbacher S (2001). The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review. Ann Periodontol 6:9-15.
5. Beck JD, Elter JR, Heiss G, Couper D, Mauriello SM, Offenbacher S (2001). Relationship of periodontal disease to carotid artery intimamedia wall thickness: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol 21:1816-1822.
6. Belardelli F, Ferrantini M (2002). Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol 23:201-208.
7. Biet F, Locht C, Kremer L (2002). Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med 80:147-162.
8. Blankenberg S, Luc G, Ducimetiere P, Arveiler D, Ferneres J, Amouyel P, et al. (2003). Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 108:2453-2459.
9. Bohn E, Sing A, Zumbihl R, Bielfeldt C, Okamura H, Kurimoto M, et al. (1998). IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol 160:299-307.
10. Born TL, Thomassen E, Bird TA, Sims JE (1998). Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem 273:29445-29450.
11. Caligiuri G, Kaveri S, Nicoletti A (2005). When interleukin-18 conducts, the Preludio sounds the same no matter who plays. Arterioscler Thromb Vasc Biol 25:655-657.
12. Chandrasekar B, Vemula K, Surabhi RM, Li-Weber M, Owen-Schaub LB, Jensen LE, et al. (2004). Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin- 18-mediated human cardiac endothelial cell death. J Biol Chem 279:20221-20233.
13. Chang JT, Segal BM, Nakanishi K, Okamura H, Shevach EM (2000). The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit. Eur J Immunol 30:1113-1119.
14. Chu ZL, Pio F, Xie Z, Welsh K, Krajewska M, Krajewski S, et al. (2001). A novel enhancer of the Apaf1 apoptosome involved in cytochrome cdependent caspase activation and apoptosis. J Biol Chem 276:9239-9245.
15. Contreras A, Slots J (2000). Herpesviruses in human periodontal disease. J Periodontal Res 35:3-16.
16. Contreras A, Umeda M, Chen C, Bakker I, Morrison JL, Slots J (1999a). Relationship between herpesviruses and adult periodontitis and periodontopathic bacteria. J Periodontol 70:478-484.
17. Contreras A, Zadeh HH, Nowzari H, Slots J (1999b). Herpesvirus infection of inflammatory cells in human periodontitis. Oral Microbiol Immunol 14:206-212.
18. Contreras A, Nowzari H, Slots J (2000). Herpesviruses in periodontal pocket and gingival tissue specimens. Oral Microbiol Immunol 15:15-18.
19. Cullinan MP, Westerman B, Hamlet SM, Palmer JE, Faddy MJ, Lang NP, et al. (2001). A longitudinal study of interleukin-1 gene polymorphisms and periodontal disease in a general adult population. J Clin Periodontol 28:1137-1144.
20. Delaleu N, Bickel M (2004). Interleukin-1 beta and interleukin-18: regulation and activity in local inflammation. Periodontol 2000 35:42-52.
21. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM (1993). Dental disease and risk of coronary heart disease and mortality. BMJ 306:688-691.
22. Dinarello CA (1999). Interleukin-18. Methods 19:121-132.
23. Fantuzzi G, Dinarello CA (1999). Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J Clin Immunol 19:1-11.
24. Finotto S, Siebler J, Hausding M, Schipp M, Wirtz S, Klein S, et al. (2004). Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut 53:392-400.
25. Folwaczny M, Glas J, Torok HP, Tonenchi L, Paschos E, Bauer B, et al. (2005). Polymorphisms of the interleukin-18 gene in periodontitis patients. J Clin Periodontol 32:530-534.
26. Fraser DA, Loos BG, Boman U, van Winkelhoff AJ, van der Velden U, Schenck K, et al. (2003). Polymorphisms in an interferon-gamma receptor-1 gene marker and susceptibility to periodontitis. Acta Odontol Scand 61:297-302.
27. Fujioka N, Akazawa R, Ohashi K, Fujii M, Ikeda M, Kurimoto M (1999). Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J Virol 73:2401-2409.
28. Fukushima K, Ikehara Y, Yamashita K (2005). Functional role played by the glycosylphosphatidylinositol anchor glycan of CD48 in interleukin-18-induced interferon-gamma production. J Biol Chem 280:18056-18062.
29. Gemmell E, Seymour GJ (2004). Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontology 2000 35:21-41.
30. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. (1997). Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386:619-623.
31. Grandjean-Laquerriere A, Laquerriere P, Laurent-Maquin D, Guenounou M, Phillips TM (2004). The effect of the physical characteristics of hydroxyapatite particles on human monocytes IL-18 production in vitro. Biomaterials 25:5921-5927.
32. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, et al. (1997). Activation of interferon-gamma inducing factor mediated by interleukin-1 beta converting enzyme. Science 275:206-209.
33. Ishida Y, Kondo T, Takayasu T, Iwakura Y, Mukaida N (2004a). The essential involvement of cross-talk between IFN-gamma and TGF-beta in the skin wound-healing process. J Immunol 172:1848-1855.
34. Ishida Y, Migita K, Izumi Y, Nakao K, Ida H, Kawakami A, et al. (2004b). The role of IL-18 in the modulation of matrix metalloproteinases and migration of human natural killer (NK) cells. FEBS Lett 569:156-160.
35. Johnson RB, Serio FG (2005). Interleukin-18 concentrations and the pathogenesis of periodontal disease. J Periodontol 76:785-790.
36. Jonak ZL, Trulli S, Maier C, McCabe FL, Kirkpatrick R, Johanson K, et al. (2002). High-dose recombinant interleukin-18 induces an effective Th1 immune response to murine MOPC-315 plasmacytoma. J Immunother 25(Suppl 1):S20-S27.
37. Kamma JJ, Contreras A, Slots J (2001). Herpes viruses and periodontopathic bacteria in early-onset periodontitis. J Clin Periodontol 28:879-885.
38. Kashiwamura S, Ueda H, Okamura H (2002). Roles of interleukin-18 in tissue destruction and compensatory reactions. J Immunother 25(Suppl 1):S4-S11.
39. Kato Z, Jee J, Shikano H, Mishima M, Ohki I, Ohnishi H, et al. (2003). The structure and binding mode of interleukin-18. Nat Struct Biol 10:966-971.
40. Kawakami K (2002). Interleukin-18 and host defense against infectious pathogens. J Immunother 25(Suppl 1):S12-S19.
41. Kohka H, Yoshino T, Iwagaki H, Sakuma I, Tanimoto T, Matsuo Y, et al. (1998). Interleukin-18/interferon-gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J Leukoc Biol 64:519-527.
42. Koizumi H, Sato-Matsumura KC, Nakamura H, Shida K, Kikkawa S, Matsumoto M, et al. (2001). Distribution of IL-18 and IL-18 receptor in human skin: various forms of IL-18 are produced in keratinocytes. Arch Dermatol Res 293:325-333.
43. Komai-Koma M, Gracie JA, Wei XQ, Xu D, Thomson N, McInnes IB, et al. (2003). Chemoattraction of human T cells by IL-18. J Immunol 170:1084-1090.
44. Kornman KS, Crane A, Wang HY, di Giovine FS, Newman MG, Pirk FW, et al. (1997). The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 24:72-77.
45. Lang NP, Tonetti MS, Suter J, Sorrell J, Duff GW, Kornman KS (2000). Effect of interleukin-1 gene polymorphisms on gingival inflammation assessed by bleeding on probing in a periodontal maintenance population. J Periodontal Res 35:102-107.
46. Laquerriere P, Grandjean-Laquerriere A, Jallot E, Balossier G, Frayssinet P, Guenounou M (2003). Importance of hydroxyapatite particles characteristics on cytokines production by human monocytes in vitro. Biomaterials 24:2739-2747.
47. Lee JK, Kim SH, Lewis EC, Azam T, Reznikov LL, Dinarello CA (2004). Differences in signaling pathways by IL-1beta and IL-18. Proc Natl Acad Sci USA 101:8815-8820.
48. Leung BP, Culshaw S, Gracie JA, Hunter D, Canetti CA, Campbell C, et al. (2001). A role for IL-18 in neutrophil activation. J Immunol 167:2879-2886.
49. Li J, Mbow ML, Sun L, Li L, Yang G, Griswold DE, et al. (2004). Induction of dendritic cell maturation by IL-18. Cell Immunol 227:103-108.
50. Li S, Goorha S, Ballou LR, Blatteis CM (2003). Intracerebroventricular interleukin-6, macrophage inflammatory protein-1 beta and IL-18: pyrogenic and PGE(2)-mediated? Brain Res 992:76-84.
51. Liew FY, Wei XQ, McInnes IB (2003). Role of interleukin 18 in rheumatoid arthritis. Ann Rheum Dis 62(Suppl 2):ii48-ii50.
52. Loos BG, Leppers-Van de Straat FG, Van de Winkel JG, Van der Velden U (2003). Fcgamma receptor polymorphisms in relation to periodontitis. J Clin Periodontol 30:595-602.
53. Lorey SL, Huang YC, Sharma V (2004). Constitutive expression of interleukin-18 and interleukin-18 receptor mRNA in tumour derived human B-cell lines. Clin Exp Immunol 136:456-462.
54. Lotze MT, Tahara H, Okamura H (2002). Interleukin-18 as a novel, distinct, and distant member of the interleukin-1 family promoting development of the adaptive immune response: the interleukin-18 issue of the Journal of Immunotherapy. J Immunother 25(Suppl 1):S1-S3.
55. Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, et al. (2001). Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104:1598-1603.
56. Martinon F, Burns K, Tschopp J (2002). The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417-426.
57. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006). Goutassociated uric acid crystals activate the NALP3 inflammasome. Nature 440:237-241.
58. Mercado FB, Marshall RI, Klestov AC, Bartold PM (2001). Relationship between rheumatoid arthritis and periodontitis. J Periodontol 72:779-787.
59. Michalowicz BS (1994a). Genetic risk factors for the periodontal diseases. Compendium 15:1036, 1038, 1040 passim.
60. Michalowicz BS (1994b). Genetic and heritable risk factors in periodontal disease. J Periodontol 65(5 Suppl):479-488.
61. Miranda LA, Fischer RG, Sztajnbok FR, Figueredo CM, Gustafsson A (2003). Periodontal conditions in patients with juvenile idiopathic arthritis. J Clin Periodontol 30:969-974.
62. Miranda LA, Fischer RG, Sztajnbok FR, Johansson A, Figueredo CM, Gustafsson A (2005). Increased interleukin-18 in patients with juvenile idiopathic arthritis and early attachment loss. J Periodontol 76:75-82.
63. Mosmann TR, Sad S (1996). The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146.
64. Muhl H, Pfeilschifter J (2004). Interleukin-18 bioactivity: a novel target for immunopharmacological anti-inflammatory intervention. Eur J Pharmacol 500:63-71.
65. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001a). Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12:53-72.
66. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001b). Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423-474.
67. Nicoletti F, Conget I, Di Marco R, Speciale AM, Morinigo R, Bendtzen K, et al. (2001). Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia 44:309-311.
68. Nolan KF, Greaves DR, Waldmann H (1998). The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci. Genomics 51:161-163.
69. Nold M, Goede A, Eberhardt W, Pfeilschifter J, Muhl H (2003). IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10. Naunyn Schmiedebergs Arch Pharmacol 367:68-75.
70. O'Garra A (1998). Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275-283.
71. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al. (1995). Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378:88-91.
72. Opal SM, DePalo VA (2000). Anti-inflammatory cytokines. Chest 117:1162-1172.
73. Orozco A, Gemmell E, Bickel M, Seymour GJ (2006). Interleukin-1 beta, interleukin-12 and interleukin-18 levels in gingival fluid and serum of patients with gingivitis and periodontitis. Oral Microbiol Immunol 21:256-260.
74. Page RC, Schroeder HE (1976). Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 34:235-249.
75. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS (1997). Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 14:216-248.
76. Pages F, Galon J, Karaschuk G, Dudziak D, Camus M, Lazar V, et al. (2005). Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells. Blood 105:1632-1639.
77. Parikh CR, Mishra J, Thiessen-Philbrook H, Dursun B, Ma Q, Kelly C, et al. (2006). Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 70:199-203.
78. Parnet P, Garka KE, Bonnert TP, Dower SK, Sims JE (1996). IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J Biol Chem 271:3967-3970.
79. Petrilli V, Papin S, Tschopp J (2005). The inflammasome. Curr Biol 15:R581.
80. Pirhonen J (2001). Regulation of IL-18 expression in virus infection. Scand J Immunol 53:533-539.
81. Reddy P (2004). Interleukin-18: recent advances. Curr Opin Hematol 11:405-410.
82. Rouabhia M, Ross G, Page N, Chakir J (2002). Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation. Infect Immun 70:7073-7080.
83. Schneider E, Tonanny MB, Lisbonne M, Leite-de-Moraes M, Dy M (2004). Pro-Th1 cytokines promote Fas-dependent apoptosis of immature peripheral basophils. J Immunol 172:5262-5268.
84. Seta Y, Kanda T, Tanaka T, Arai M, Sekiguchi K, Yokoyama T, et al. (2000a). Interleukin 18 in acute myocardial infarction. Heart 84:668-669.
85. Seta Y, Kanda T, Tanaka T, Arai M, Sekiguchi K, Yokoyama T, et al. (2000b). Interleukin-18 in patients with congestive heart failure: induction of atrial natriuretic peptide gene expression. Res Commun Mol Pathol Pharmacol 108:87-95.
86. Seymour GJ, Gemmell E (2001). Cytokines in periodontal disease: where to from here? Acta Odontol Scand 59:167-173.
87. Seymour GJ, Taylor JJ (2004). Shouts and whispers: an introduction to immunoregulation in periodontal disease. Periodontol 2000 35:9-13.
88. Sigal LH (2005). Basic science for the clinician 34: Interleukins of current clinical relevance (part II). J Clin Rheumatol 11:34-39.
89. Slots J, Contreras A (2000). Herpesviruses: a unifying causative factor in periodontitis? Oral Microbiol Immunol 15:277-280.
90. Sugawara S, Uehara A, Nochi T, Yamaguchi T, Ueda H, Sugiyama A, et al. (2001). Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol 167:6568-6575.
91. Tardif F, Ross G, Rouabhia M (2004). Gingival and dermal fibroblasts produce interleukin-1 beta converting enzyme and interleukin-1 beta but not interleukin-18 even after stimulation with lipopolysaccharide. J Cell Physiol 198:125-132.
92. Tenger C, Sundborger A, Jawien J, Zhou X (2005). IL-18 accelerates atherosclerosis accompanied by elevation of IFN-gamma and CXCL16 expression independently of T cells. Arterioscler Thromb Vasc Biol 25:791-796.
93. Tominaga K, Yoshimoto T, Torigoe K, Kurimoto M, Matsui K, Hada T, et al. (2000). IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int Immunol 12:151-160.
94. Tschoeke SK, Oberholzer A, Moldawer LL (2006), Interleukin-18: a novel prognostic cytokine in bacteria-induced sepsis. Crit Care Med 34:1225-1233.
95. Tschopp J, Martinon F, Burns K (2003). NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 4:95-104.
96. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, et al. (1996). Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 156:4274-4279.
97. Walker W, Rotondo D (2004). Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis. Immunology 111:298-305.
98. Wittmann M, Purwar R, Hartmann C, Gutzmer R, Werfel T (2005). Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases. J Invest Dermatol 124:1225-1233.
99. Xu D, Chan WL, Leung BP, Hunter D, Schulz K, Carter RW, et al. (1998). Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp 188:1485-1492.
100. Yamada N, Niwa S, Tsujimura T, Iwasaki T, Sugihara A, Futani H, et al. (2002). Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity. Bone 30:901-908.
101. Yamamura M, Kawashima M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, et al. (2001). Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum 44:275-285.
102. Yndestad A, Holm AM, Muller F, Simonsen S, Froland SS, Gullestad L, et al. (2003). Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res 60:141-146.
103. Yoshimoto T, Mizutani H, Tsutsui H, Noben-Trauth N, Yamanaka K, Tanaka M, et al. (2000). IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol 1:132-137.